ESC Professional Premium Access

Unravelling the role of SOCS3 in aortic valve stenosis

Congress Presentation

About the speaker

Doctor Hannah Billig

Heartcenter Bonn, University Hospital Bonn, Bonn (Germany)
0 follower

5 more presentations in this session

Loss of ceramide synthase 5 reduces the development of aortic valve stenosis in mice with high fat diet.

Speaker: Ms L. Reese (Bonn, DE)


Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis

Speaker: Ms M. Kopytek (Krakow, PL)


Specific gene domains most commonly affected by CHIP-driver mutations predicting mortality in severe aortic stenosis after transcatheter aortic valve implantation

Speaker: Associate Professor S. Mas-Peiro (Frankfurt, DE)


Histology-verified myocardial fibrosis and quantification in severe AS patients: correlation with non-invasive LV myocardial tissue assessment

Speaker: Doctor S. Maltes (Lisbon, PT)


Autologous or bovine pericardium for aortic cusp replacement? Histomorphological and biomechanical properties as decision making tools

Speaker: Doctor C. Dittfeld (Dresden, DE)


Access the full session

Pathomechanisms and treatment of valve disease

Speakers: Doctor H. Billig, Ms L. Reese, Ms M. Kopytek, Associate Professor S. Mas-Peiro, Doctor S. Maltes...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb